![Russell Hawkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Hawkinson
Nessuna posizione attualmente
Profilo
Russell Hawkinson worked as Vice President-Finance & Accounting at CTI BioPharma Corp.
from 2006 to 2007.
He then worked as Vice President-Finance at Corixa Corp.
from 1995 to 2005.
From 2007 to 2018, he served as Chief Financial Officer at Theraclone Sciences, Inc. He also worked as an Audit Senior Manager at Ernst & Young LLP (Missouri).
In addition, he worked as Chief Financial Officer at OncoResponse, Inc. from 2015 to 2018.
Most recently, he served as Senior Vice President-Finance at Silverback Therapeutics, Inc. from 2020 to 2022.
Mr. Hawkinson received his undergraduate degree from the University of Washington.
Precedenti posizioni note di Russell Hawkinson
| Società | Posizione | Fine |
|---|---|---|
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Direttore Finanziario/CFO | 01/06/2018 |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Direttore Finanziario/CFO | 01/06/2018 |
| CTI BIOPHARMA CORP. | Direttore Finanziario/CFO | 01/01/2007 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Direttore Finanziario/CFO | 01/01/2005 |
| ARS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | - |
Formazione di Russell Hawkinson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
39
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
